secwatch.observer — SEC 8-K summary
======================================

Issuer:     HTG MOLECULAR DIAGNOSTICS, INC (—)
CIK:        0001169987
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0000950170-23-023963
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies HTG Molecular of delisting risk for equity below $2.5M
----------------------------------------------------------------------

- Nasdaq notice on May 18, 2023: stockholders' equity fell below $2.5M as of March 31, 2023.
- Company must submit a compliance plan by July 3, 2023 under Nasdaq Rule 5550(b).
- If plan is accepted, Nasdaq may grant up to 180-day extension for evidence of compliance.
- No assurance of regaining compliance; delisting remains a possibility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1169987/000095017023023963/0000950170-23-023963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1169987/000095017023023963/htgm-20230518.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-023963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer